SANOCHEMIA PHARMAZEUTIKA AG

Inactive Instrument

News SANOCHEMIA Pharmazeutika AG

Equities

SAC

AT0000776307

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

EOSS Technology GmbH, Wirtschaft Burgenland GmbH – WiBuG and b·e·imaging·GmbH acquired SANOCHEMIA Pharmazeutika AG from bew Beteiligungs GmbH and other shareholders.	15/20/15	CI
SANOCHEMIA Pharmazeutika AG announced that it has received €6 million in funding from bew Beteiligungs GmbH	13/20/13	CI
Bew Beteiligungs GmbH acquired an unknown stake in SANOCHEMIA Pharmazeutika AG from Inphasearch AG.	10/20/10	CI
SANOCHEMIA Pharmazeutika AG announced that it expects to receive €6 million in funding from bew Beteiligungs GmbH	17/20/17	CI
SANOCHEMIA Pharmazeutika : PTA-Adhoc Sanochemia Pharmazeutika AG aims for plan insolvency	09/19/09	PU
SANOCHEMIA Pharmazeutika AG Announces Positive Topline Results from Phase 2 Star Study of Tolperisone in Acute Muscle Spasms of the Back in the U.S	24/19/24	CI
Sanochemia Pharmazeutika Ag Names Timo Bender as CEO, Effective February 1, 2019	25/19/25	CI
B·e·imaging·GmbH acquired 14.5% stake in SANOCHEMIA Pharmazeutika AG from Inphasearch AG.	18/19/18	CI
SANOCHEMIA Pharmazeutika AG Announces Board Changes	06/18/06	CI
Sanochemia Pharmazeutika Ag Reports Earnings Results for the Six Months of the Year 2018	24/18/24	CI
Sanochemia Pharmazeutika AG Announces Sales Results for the First Quarter of Fiscal 2017; Provides Earnings Guidance for the Full Year of Fiscal 2017	23/17/23	CI
Invesa AG and Inphasearch AG cancelled the acquisition of 34.9% stake in Sanochemia Pharmazeutika AG from Sanochemia Ltd.	22/17/22	CI
Sanochemia Announces Earnings Results for the Full Year of Fiscal 2016	31/16/31	CI
Invesa AG and Inphasearch AG agreed to acquire 34.9% stake in Sanochemia Pharmazeutika AG from Sanochemia Ltd.	22/16/22	CI
Sanochemia Extends Contracts with Janssen N.V	16/15/16	CI
Sanochemia Reports Preliminary Earnings Results for the Fiscal Year 2013	10/13/10	CI
Link Healthcare Obtains Extensive Regional Rights to Secrelux from Sanochemia Pharmazeutika AG	14/13/14	CI
Sanochemia Pharmazeutika AG's Equity Buyback has expired	22/12/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
SAC Stock
News SANOCHEMIA Pharmazeutika AG

Protect and grow your investments with the help of our experts

Securing my Investments

fermer